Abstract
We have assessed if high-frequency ultrasound (US) can enhance nonviral gene transfer to the mouse lung. Cationic lipid GL67/pDNA, polyethylenimine (PEI)/pDNA and naked plasmid DNA (pDNA) were delivered via intranasal instillation, mixed with Optison microbubbles, and the animals were then exposed to 1 MHz US. Addition of Optison alone significantly reduced the transfection efficiency of all three gene transfer agents. US exposure did not increase GL67/pDNA or PEI/pDNA gene transfer compared to Optison-treated animals. However, it increased naked pDNA transfection efficiency by approximately 15-fold compared to Optison-treated animals, suggesting that despite ultrasound being attenuated by air in the lung, sufficient energy penetrates the tissue to increase gene transfer. US-induced lung haemorrhage, assessed histologically, increased with prolonged US exposure. The left lung was more affected than the right and this was mirrored by a lesser increase in naked pDNA gene transfer, in the left lung. The positive effect of US was dependent on Optison, as in its absence US did not increase naked pDNA transfection efficiency. We have thus established proof of principle that US can increase nonviral gene transfer, in the air-filled murine lung.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ferrari S, Geddes DM, Alton EW . Barriers to and new approaches for gene therapy and gene delivery in cystic fibrosis. Adv Drug Deliv Rev 2002; 54: 1373–1393.
Ferrari S, Kitson C, Farley R, Steel R, Marriott C, Parkins DA et al. Mucus altering agents as adjuncts for nonviral gene transfer to airway epithelium. Gene Therapy 2001; 8: 1380–1386.
Sinn PL, Shah AJ, Donovan MD, McCray Jr PB . Viscoelastic gel formulations enhance airway epithelial gene transfer with viral vectors. Am J Respir Cell Mol Biol 2005; 32: 404–410.
Wang G, Zabner J, Deering C, Launspach J, Shao J, Bodner M et al. Increasing epithelial junction permeability enhances gene transfer to airway epithelia in vivo. Am J Respir Cell Mol Biol 2000; 22: 129–138.
Caplen NJ, Alton EW, Middleton PG, Dorin JR, Stevenson BJ, Gao X et al. Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Nat Med 1995; 1: 39–46.
Flotte TR, Zeitlin PL, Reynolds TC, Heald AE, Pedersen P, Beck S et al. Phase I trial of intranasal and endobronchial administration of a recombinant adeno-associated virus serotype 2 (rAAV2)-CFTR vector in adult cystic fibrosis patients: a two-part clinical study. Hum Gene Ther 2003; 14: 1079–1088.
Hyde SC, Southern KW, Gileadi U, Fitzjohn EM, Mofford KA, Waddell BE et al. Repeat administration of DNA/liposomes to the nasal epithelium of patients with cystic fibrosis. Gene Therapy 2000; 7: 1156–1165.
Hyde SC, Gill DR, Higgins CF, Trezise AE, MacVinish LJ, Cuthbert AW et al. Correction of the ion transport defect in cystic fibrosis transgenic mice by gene therapy. Nature 1993; 362: 250–255.
Porteous DJ, Dorin JR, McLachlan G, Vidson-Smith H, Davidson H, Stevenson BJ et al. Evidence for safety and efficacy of DOTAP cationic liposome mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Gene Therapy 1997; 4: 210–218.
Alton EW, Stern M, Farley R, Jaffe A, Chadwick SL, Phillips J et al. Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: a double-blind placebo-controlled trial. Lancet 1999; 353: 947–954.
Ziady AG, Kelley TJ, Milliken E, Ferkol T, Davis PB . Functional evidence of CFTR gene transfer in nasal epithelium of cystic fibrosis mice in vivo following luminal application of DNA complexes targeted to the serpin-enzyme complex receptor. Mol Ther 2002; 5: 413–419.
Konstan MW, Davis PB, Wagener JS, Hilliard KA, Stern RC, Milgram LJ et al. Compacted DNA nanoparticles administered to the nasal mucosa of cystic fibrosis subjects are safe and demonstrate partial to complete cystic fibrosis transmembrane regulator reconstitution. Hum Gene Ther 2004; 15: 1255–1269.
Miller DL, Song J . Tumor growth reduction and DNA transfer by cavitation-enhanced high-intensity focused ultrasound in vivo. Ultrasound Med Biol 2003; 29: 887–893.
Miller DL, Song J . Lithotripter shock waves with cavitation nucleation agents produce tumor growth reduction and gene transfer in vivo. Ultrasound Med Biol 2002; 28: 1343–1348.
Koch S, Pohl P, Cobet U, Rainov NG . Ultrasound enhancement of liposome-mediated cell transfection is caused by cavitation effects. Ultrasound Med Biol 2000; 26: 897–903.
Lawrie A, Brisken AF, Francis SE, Tayler DI, Chamberlain J, Crossman DC et al. Ultrasound enhances reporter gene expression after transfection of vascular cells in vitro. Circulation 1999; 99: 2617–2620.
Liang HD, Lu QL, Xue SA, Halliwell M, Kodama T, Cosgrove DO et al. Optimisation of ultrasound-mediated gene transfer (sonoporation) in skeletal muscle cells. Ultrasound Med Biol 2004; 30: 1523–1529.
Anwer K, Kao G, Proctor B, Anscombe I, Florack V, Earls R et al. Ultrasound enhancement of cationic lipid-mediated gene transfer to primary tumors following systemic administration. Gene Therapy 2000; 7: 1833–1839.
Amabile PG, Waugh JM, Lewis TN, Elkins CJ, Janas W, Dake MD . High-efficiency endovascular gene delivery via therapeutic ultrasound. J Am Coll Cardiol 2001; 37: 1975–1980.
Christiansen JP, French BA, Klibanov AL, Kaul S, Lindner JR . Targeted tissue transfection with ultrasound destruction of plasmid-bearing cationic microbubbles. Ultrasound Med Biol 2003; 29: 1759–1767.
Miao CH, Brayman AA, Loeb KR, Ye P, Zhou L, Mourad P et al. Ultrasound enhances gene delivery of human factor IX plasmid. Hum Gene Therapy 2005; 16: 893–905.
Shohet RV, Chen S, Zhou YT, Wang Z, Meidell RS, Unger RH et al. Echocardiographic destruction of albumin microbubbles directs gene delivery to the myocardium. Circulation 2000; 101: 2554–2556.
Liu J, Lewis TN, Prausnitz MR . Non-invasive assessment and control of ultrasound-mediated membrane permeabilization. Pharm Res 1998; 15: 918–924.
Taniyama Y, Tachibana K, Hiraoka K, Aoki M, Yamamoto S, Matsumoto K et al. Development of safe and efficient novel nonviral gene transfer using ultrasound: enhancement of transfection efficiency of naked plasmid DNA in skeletal muscle. Gene Therapy 2002; 9: 372–380.
Podell S, Burrascano C, Gaal M, Golec B, Maniquis J, Mehlhaff P . Physical and biochemical stability of Optison, an injectable ultrasound contrast agent. Biotechnol Appl Biochem 1999; 30: 213–223.
Li T, Tachibana K, Kuroki M, Kuroki M . Gene transfer with echo-enhanced contrast agents: comparison between Albunex, Optison, and Levovist in mice – initial results. Radiology 2003; 229: 423–428.
Duvshani-Eshet M, Baruch L, Kesselman E, Shimoni E, Machluf M . Therapeutic ultrasound-mediated DNA to cell and nucleus: bioeffects revealed by confocal and atomic force microscopy. Gene Therapy 2006; 13: 163–172.
Martin K, Ramnarine KV . Frequency, speed and wavelength. In: Hoskins PR, Thrush A, Martin K, Whittingham TA (eds). Diagnostic Ultrasound: Physics and Equipment. London: Greenwich Medical Media, 2002, pp 7–22.
Emerson M, Renwick L, Tate S, Rhind S, Milne E, Painter HA et al. Transfection efficiency and toxicity following delivery of naked plasmid DNA and cationic lipid-DNA complexes to ovine lung segments. Mol Therapy 2003; 8: 646–653.
Rudolph C, Ortiz A, Schillinger U, Jauernig J, Plank C, Rosenecker J . Methodological optimization of polyethylenimine (PEI)-based gene delivery to the lungs of mice via aerosol application. J Gene Med 2005; 7: 59–66.
Gill DR, Smyth SE, Goddard CA, Pringle IA, Higgins CF, Colledge WH et al. Increased persistence of lung gene expression using plasmids containing the ubiquitin C or elongation factor 1alpha promoter. Gene Therapy 2001; 8: 1539–1546.
Lu QL, Liang HD, Partridge T, Blomley MJ . Microbubble ultrasound improves the efficiency of gene transduction in skeletal muscle in vivo with reduced tissue damage. Gene Therapy 2003; 10: 396–405.
Mehier-Humbert S, Bettinger T, Yan F, Guy RH . Ultrasound-mediated gene delivery: kinetics of plasmid internalization and gene expression. J Control Release 2005; 104: 203–211.
Mehier-Humbert S, Bettinger T, Yan F, Guy RH . Plasma membrane poration induced by ultrasound exposure: implication for drug delivery. J Control Release 2005; 104: 213–222.
Rudolph C, Muller RH, Rosenecker J . Jet nebulization of PEI/DNA polyplexes: physical stability and in vitro gene delivery efficiency. J Gene Med 2002; 4: 66–74.
Carstensen EL, Gracewski S, Dalecki D . The search for cavitation in vivo. Ultrasound Med Biol 2000; 26: 1377–1385.
American Institute of Ultrasound in Medicine. Section 4 – Bioeffects in tissues with gas bodies. J Ultrasound Med 2000; 19: 97–108.
Dalecki D, Child SZ, Raeman CH, Cox C, Penney DP, Carstensen EL . Age dependence of ultrasonically induced lung hemorrhage in mice. Ultrasound Med Biol 1997; 23: 767–776.
American Institute of Ultrasound in Medicine. Section 3 – Selected biological properties of tissues: potential determinants of susceptibility to ultrasound-induced bioeffects. J Ultrasound Med 2000; 19: 85–96.
Gautam A, Densmore CL, Xu B, Waldrep JC . Enhanced gene expression in mouse lung after PEI-DNA aerosol delivery. Mol Therapy 2000; 2: 63–70.
Hillery E, Cheng S, Geddes D, Alton E . Effects of altering dosing on cationic liposome-mediated gene transfer to the respiratory epithelium. Gene Therapy 1999; 6: 1313–1316.
Wiseman JW, Goddard CA, McLelland D, Colledge WH . A comparison of linear and branched polyethylenimine (PEI) with DCChol/DOPE liposomes for gene delivery to epithelial cells in vitro and in vivo. Gene Therapy 2003; 10: 1654–1662.
Acknowledgements
This work was supported by UK Cystic Fibrosis Trust, through a grant to the UK Cystic Fibrosis Gene Therapy Consortium.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Xenariou, S., Griesenbach, U., Liang, HD. et al. Use of ultrasound to enhance nonviral lung gene transfer in vivo. Gene Ther 14, 768–774 (2007). https://doi.org/10.1038/sj.gt.3302922
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3302922
Keywords
This article is cited by
-
A Comprehensive Review of Current Perspectives on Novel Drug Delivery Systems and Approaches for Lung Cancer Management
Journal of Pharmaceutical Innovation (2022)
-
Enhanced Cellular Uptake and Gene Silencing Activity of Survivin-siRNA via Ultrasound-Mediated Nanobubbles in Lung Cancer Cells
Pharmaceutical Research (2020)
-
The murine lung as a factory to produce secreted intrapulmonary and circulatory proteins
Gene Therapy (2018)
-
Evaluation of in vivo antitumor effects of ANT2 shRNA delivered using PEI and ultrasound with microbubbles
Gene Therapy (2015)
-
Effects of shRNA-Mediated SOX9 Inhibition on Cell Proliferation and Apoptosis in Human HCC Cell Line Hep3B Mediated by Ultrasound-Targeted Microbubble Destruction (UTMD)
Cell Biochemistry and Biophysics (2015)